This post was originally published on this site
Moderna shares rose 6% in extended trade after the announcement. The COVID-19 vaccine maker’s stock has surged over 150% this year, elevating its market capitalization to about $100 billion.
Britain’s AstraZeneca (NASDAQ:AZN) said last December it would acquire U.S. biotech Alexion in a $39 billion deal.
